Loading...
Market
Outcome of BMA's evaluation of Cass Review by end of 2024?
2
Resolution / Starting Odds
Endorse the Cass Review • 25%
Critique the Cass Review • 25%
Request further research • 25%
No official stance • 25%
Official statements or publications from the British Medical Association (BMA)
Story
BMA to Evaluate Cass Review on Pediatric Gender Transition Treatment, Despite High Court Endorsement
Jul 31, 2024, 03:44 PM
The British Medical Association (BMA) has announced it will undertake an evaluation of the Cass Review, which found that pediatric gender transition treatment is based on 'remarkably weak evidence.' This decision follows a recent vote by the BMA's Council in favor of a motion to publicly critique the review. The announcement comes shortly after the High Court described the Cass Review as 'the best and most up to date scientific evidence available.' Additionally, the High Court ruled that ministers have the right under the 1968 Medicines Act to make decisions based on the Cass Review. The BMA's move has sparked significant debate within the medical community.
View original story
Similar markets
BMA wins and NHS halts PA recruitment • 25%
BMA wins but no change in NHS policy • 25%
GMC wins and NHS continues PA recruitment • 25%
GMC wins but NHS modifies PA recruitment policy • 25%
New budget increase agreed • 25%
No change in budget • 25%
Temporary suspension of industrial action • 25%
Other outcome • 25%
Passed without changes • 25%
Passed with amendments • 25%
Not passed • 25%
Deferred to 2025 • 25%
Full implementation • 25%
Partial implementation • 25%
No implementation • 25%
Implementation pending • 25%
New significant information on JFK assassination • 25%
New significant information on RFK assassination attempt • 25%
New significant information on Trump assassination attempt • 25%
No new significant information • 25%
No major issues found • 25%
Minor issues resolved • 25%
Major issues with fines • 25%
Major issues without fines • 25%
Guidance upheld • 25%
Guidance overturned • 25%
Settlement reached • 25%
Still pending • 25%
Finds significant bias • 25%
Finds minor bias • 25%
Finds no bias • 25%
Review inconclusive • 25%
Suspension of Yaser Jabbar • 25%
Legal action against Yaser Jabbar • 25%
Policy changes at the hospital • 25%
No significant action • 25%
